(Q40461869)

20 September 2017

title

Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells. (English)

1 reference

20 September 2017

Carsten Finger

1

1 reference

20 September 2017

Yuansheng Sun

2

1 reference

20 September 2017

Laura Sanz

3

1 reference

20 September 2017

Luis Alvarez-Vallina

4

1 reference

20 September 2017

Christian J Buchholz

5

1 reference

20 September 2017

Klaus Cichutek

6

1 reference

20 September 2017

publication date

1 May 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

12

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

464-474

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700805

20 September 2017

exact match

0 references

cites work

Gene therapy for cancer: what have we done and where are we going?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Cancer gene therapy: hard lessons and new courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Replicating vectors for gene therapy of cancer: risks, limitations and prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Selectively replicating adenoviruses for oncolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Strategies for achieving multiple layers of selectivity in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

21 January 2018

Viral vector targeting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Gene therapy for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Replication-competent Moloney murine leukemia virus carrying a bacterial suppressor tRNA gene: selective cloning of proviral and flanking host sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

In vivo selection of protease cleavage sites from retrovirus display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Expression of novel 400-kDa laminin chains by mouse and bovine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Laminin isoforms and epithelial development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Expression of heterologous genes from an IRES translational cassette in replication competent murine leukemia virus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Processing of a fusion protein by endoprotease in COS-1 cells for secretion of mature peptide by using a chimeric expression vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Clinical research. Gene therapy a suspect in leukemia-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Tissue-specific transcriptional targeting of a replication-competent retroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

7 January 2021

Construction of a replication-competent murine retrovirus vector expressing the human immunodeficiency virus type 1 tat transactivator protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

7 January 2021

Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3, and Kit ligands and RetroNectin culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

7 January 2021

Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700805

1 reference

Dimensions Publication ID

20 September 2017

1022181138

0 references

1 reference